Price
Target price
€24.51
€24.51
-0.850%
-0.21
-0.850%
-
12:13 / Tradegate
WKN: 853849 / Symbol: TKPHF / Name: Takeda Pharma / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Takeda Pharmaceutical Co Ltd Stock
The price for the Takeda Pharmaceutical Co Ltd stock decreased slightly today. Compared to yesterday there is a change of -€0.210 (-0.850%).
For the coming years our community has positive and negative things to say abot the Takeda Pharmaceutical Co Ltd stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Takeda Pharmaceutical Co Ltd in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Takeda Pharmaceutical Co Ltd vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd | -0.850% | 1.436% | -0.842% | -18.631% | -4.740% | -12.309% | -21.536% |
Santen Pharmaceutical Corp Ltd. | -0.530% | 2.717% | 8.621% | 16.667% | 6.180% | -10.849% | -26.721% |
Dainippon Sumitomo Pharma | -8.400% | 11.215% | 0.000% | -55.094% | -18.493% | -83.699% | -87.375% |
Chugai Pharmaceutical Co Ltd | 4.480% | -3.347% | -6.599% | 17.172% | -15.414% | -7.952% | - |
Comments
News
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement